Using prophylactic, but not tocolytic, magnesium sulfate to reduce cerebral palsy related to prematurity: what dose, and what about infant mortality?
about
Antenatal Magnesium Sulfate, Necrotizing Enterocolitis, and Death among Neonates < 28 Weeks GestationThe use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection.Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain.Intrapartum magnesium sulfate and need for intensive delivery room resuscitation.
P2860
Using prophylactic, but not tocolytic, magnesium sulfate to reduce cerebral palsy related to prematurity: what dose, and what about infant mortality?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using prophylactic, but not to ...... d what about infant mortality?
@en
Using prophylactic, but not to ...... d what about infant mortality?
@nl
type
label
Using prophylactic, but not to ...... d what about infant mortality?
@en
Using prophylactic, but not to ...... d what about infant mortality?
@nl
prefLabel
Using prophylactic, but not to ...... d what about infant mortality?
@en
Using prophylactic, but not to ...... d what about infant mortality?
@nl
P2860
P921
P356
P1476
Using prophylactic, but not to ...... d what about infant mortality?
@en
P2093
Peter G Pryde
Robert Mittendorf
P2860
P304
P356
10.1515/JPM.2011.036
P577
2011-04-14T00:00:00Z